|
1
|
Maitra A and Kumar V: The lung and upper
respiratory tract. Robbins Basic Pathology. 7th edition. Saunders;
Philadelphia: pp. 453–509. 2002
|
|
2
|
Battifora H and McCaughey E: Tumors of the
Serosal Membranes. Armed Forces Institute of Pathology; Washington,
DC: 1994
|
|
3
|
Thomason R, Schlegel W, Lucca M, et al:
Primary malignant mesothelioma of the pericardium. Case report and
literature review. Tex Heart Inst J. 21:170–174. 1994.PubMed/NCBI
|
|
4
|
Kasdon EJ: Malignant mesothelioma of the
tunica vaginalis propria testis. Report of two cases Cancer.
23:1144–1150. 1969.PubMed/NCBI
|
|
5
|
Kozlowski H and Zoltowska A: Mesothelioma
of spermatic cord. Neoplasma. 15:97–100. 1968.PubMed/NCBI
|
|
6
|
Imura J, Ichikawa K, Takeda J, Iwasaki Y,
et al: Localized malignant mesothelioma of the epithelial type
occurring as a primary hepatic neoplasm: a case report with review
of the literature. APMIS. 110:789–794. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Leonardou P, Semelka RC, Kanematsu M, et
al: Primary malignant mesothelioma of the liver: MR imaging
findings. Magn Reson Imaging. 21:1091–1093. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gütgemann I, Standop J and Fischer HP:
Primary intrahepatic malignant mesothelioma of epithelioid type.
Virchows Arch. 448:655–658. 2006.PubMed/NCBI
|
|
9
|
Kim DS, Lee SG, Jun SY, et al: Primary
malignant mesothelioma developed in liver. Hepatogastroenterology.
55:1081–1084. 2008.PubMed/NCBI
|
|
10
|
Sasaki M, Araki I, Yasui T, et al: Primary
localized malignant biphasic mesothelioma of the liver in a patient
with asbestosis. World J Gastroenterol. 15:615–621. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Buchholz BM, Gütgemann I, Fischer HP, et
al: Lymph node dissection in primary intrahepatic malignant
mesothelioma: case report and implications for diagnosis and
therapy. Langenbecks Arch Surg. 394:1123–1130. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Husain AN, Colby TV, Ordóñez NG, et al:
Guidelines for pathologic diagnosis of malignant mesothelioma: a
consensus statement from the International Mesothelioma Interest
Group. Arch Pathol Lab Med. 133:1317–1331. 2009.PubMed/NCBI
|
|
13
|
Yates DH, Corrin B, Stidolph PN and Browne
K: Malignant mesothelioma in south east England:
clinicopathological experience of 272 cases. Thorax. 52:507–512.
1997.PubMed/NCBI
|
|
14
|
Borasio P, Berruti A, Billé A, et al:
Malignant pleural mesothelioma: clinicopathologic and survival
characteristics in a consecutive series of 394 patients. Eur J
Cardiothorac Surg. 33:307–313. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gemba K, Fujimoto N, Kato K, et al:
National survey of malignant mesothelioma and asbestos exposure in
Japan. Cancer Sci. 103:483–490. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Law MR, Hodson ME and Heard BE: Malignant
mesothelioma of the pleura: relation between histological type and
clinical behaviour. Thorax. 37:810–815. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abdel Rahman AR, Gaafar RM, Baki HA, et
al: Prevalence and pattern of lymph node metastasis in malignant
pleural mesothelioma. Ann Thorac Surg. 86:391–395. 2008.PubMed/NCBI
|
|
18
|
Edwards JG, Stewart DJ, Martin-Ucar A, et
al: The pattern of lymph node involvement influences outcome after
extrapleural pneumonectomy for malignant mesothelioma. J Thorac
Cardiovasc Surg. 131:981–987. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Metintas M, Metintas S, Ak G, et al:
Epidemiology of pleural mesothelioma in a population with
non-occupational asbestos exposure. Respirology. 13:117–121. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Saad RS, Lindner JL, Lin X, et al: The
diagnostic utility of D2–40 for malignant mesothelioma versus
pulmonary carcinoma with pleural involvement. Diagn Cytopathol.
34:801–806. 2006.
|
|
21
|
Ordóñez NG: The immunohistochemical
diagnosis of mesothelioma: A comparative of epithelioid
mesothelioma and lung adenocarcinoma. Am J Surg Pathol.
27:1031–1051. 2003.PubMed/NCBI
|
|
22
|
Roberts F, Harper CM, Downie I and Burnett
RA: Immunohistochemical analysis still has a limited role in the
diagnosis of malignant mesothelioma. A study of thirteen
antibodies. Am J Clin Pathol. 116:253–262. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pu RT, Pang Y and Michael CW: Utility of
WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6)
immunostains in differentiating adenocarcinoma, squamous cell
carcinoma, and malignant mesothelioma in effusions. Diagn
Cytopathol. 36:20–25. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moch H, Oberholzer M, Christen H, et al:
Diagnostic tools for differentiating pleural mesothelioma from lung
adenocarcinoma in paraffin embedded tissue. II Design of an expert
system and its application to the diagnosis of mesothelioma.
Virchows Arch A Pathol Anat Histopathol. 423:493–496. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Attanoos RL and Gibbs AR: Pathology of
malignant mesothelioma. Histopathol. 30:403–418. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tot T: The value of cytokeratins 20 and 7
in discriminating metastatic adenocarcinoma from pleural
mesotheliomas. Cancer. 92:2727–2732. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang NP, Zee S, Zarbo RJ, et al:
Coordinate expression of cytokeratins 7 and 20 defines unique
subsets of carcinomas. Appl Immunohistochem. 3:99–107. 1995.
|
|
28
|
Chu P, Wu E and Weiss LM: Cytokeratin 7
and cytokeratin 20 expression in epithelial neoplasms: a survey of
435 cases. Mod Pathol. 13:962–972. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Treglia G, Taralli S, Calcagni ML, et al:
Is there a role for fluorine 18 fluorodeoxyglucose-positron
emission tomography and positron emission tomography/computed
tomography in evaluating patients with mycobacteriosis? A
systematic review. J Comput Assist Tomogr. 35:387–393. 2011.
View Article : Google Scholar
|
|
30
|
Das CJ, Kumar R, Balakrishnan VB, et al:
Disseminated tuberculosis masquerading as metastatic breast
carcinoma on PET-CT. Clin Nucl Med. 33:359–361. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li YJ, Cai L, Sun HR, et al: Increased FDG
uptake in bilateral adrenal tuberculosis appearing like malignancy.
Clin Nucl Med. 33:191–192. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin WY, Hung GU and Tsai SC: A pitfall of
FDG-PET image interpretation: accumulation of FDG in the dependent
area of the urinary bladder after bladder irrigation - the
usefulness of the prone position. Clin Nucl Med. 30:638–639. 2005.
View Article : Google Scholar : PubMed/NCBI
|
